Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.76%
SPX
-2.06%
IXIC
-2.39%
FTSE
-0.18%
N225
-0.41%
AXJO
-0.37%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
crvs
Corvus Pharmaceuticals
NASDAQ: CRVS
+12.12 (+150.56%)
20.17
USD
At close at Jan 20, 21:40 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Corvus Pharmaceuticals News

benzinga.com

Earnings Scheduled For November 4, 2025

Feature Image for interests on Basic Materials, Bzi-Ue, Communication Services, Consumer Cyclical from benzinga.com
3 months ago
benzinga.com

Why Is Corvus Pharmaceuticals Stock Soaring On Friday?

Feature Image for interests on Benzinga, Biotech, Briefs, Crvs from benzinga.com
9 months ago
businesswire.com

Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm

over 1 year ago
businesswire.com

Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm

over 1 year ago
finance.yahoo.com

Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Feature Image for interests on Biopharmaceutical Company, Chief Business Officer, Chief Executive Officer, Healthcare from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Corvus: Q2 Earnings Snapshot

Feature Image for interests on Automated Insights, Burlingame, California-Based Company, Corvus Pharmaceuticals Inc. from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Corvus Pharmaceuticals Granted FDA Fast Track Designation for Soquelitinib for Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Feature Image for interests on Company, Corvus, Corvus Pharmaceuticals, Fast Track Designation from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2024 Financial Results on August 6, 2024

Feature Image for interests on Biopharmaceutical Company, Healthcare, Stock from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Publication of Preclinical Data in Science Signaling Demonstrated the Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Treatment of Inflammatory Diseases

Feature Image for interests on Cell Differentiation, Clinical Trials, Company, Cornell University from finance.yahoo.com
over 1 year ago
finance.yahoo.com

T cell Lymphoma Therapeutics Research 2024: Comprehensive Insights about 90+ Companies and 90+ Pipeline Drugs

Feature Image for interests on Astex Pharmaceuticals Tolinapant, Healthcare, Pipeline Insight, Pipeline Products from finance.yahoo.com
over 1 year ago
Join our newsletter to keep up to date with us!

Latest Cashu News

publisher logo
Cashu

Corvus Pharmaceuticals Advances CPI-818 in Promising Immuno-Oncology Research and Clinical Trials

3 months ago
publisher logo
Cashu

Corvus Pharmaceuticals (CRVS) Advances Soquelitinib Research for Atopic Dermatitis Treatment

8 months ago
publisher logo
Cashu

Corvus Pharmaceuticals (CRVS) Reports Promising Phase 1 Findings for Soquelitinib in Atopic Dermatitis

9 months ago